Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Lechowicz

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bone Marrow Transplantation|July 16, 2008
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphomaS Murali, E Winton, E K Waller, et al.
Bone Marrow Transplantation|October 29, 2013
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donorsA A Langston, J M Prichard, S Muppidi, et al.
Bone Marrow Transplantation|July 19, 2016
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumorsZ DeFilipp, C B Rosand, D A Goldstein, et al.
Bone Marrow Transplantation|July 29, 2014
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeM J Lechowicz, H M Lazarus, J Carreras, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bone Marrow Transplantation|July 16, 2008
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphomaS Murali, E Winton, E K Waller, et al.
Bone Marrow Transplantation|October 29, 2013
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donorsA A Langston, J M Prichard, S Muppidi, et al.
Bone Marrow Transplantation|July 19, 2016
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumorsZ DeFilipp, C B Rosand, D A Goldstein, et al.
Bone Marrow Transplantation|July 29, 2014
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeM J Lechowicz, H M Lazarus, J Carreras, et al.
Pageof 2